Spondyloarthritis & psoriatic arthritis

Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development

Rheumatology (Oxford)Published Cross-sectional study

Main finding · PsA prevalenceResult — go to the resultAdjusted odds ratio 0.228

Authors' conclusion

This study provides meaningful and concordant evidence supporting the significant role of different classes of biologics in reducing the likelihood of peripheral and axial PsA development.

Study context

Population
Patients with psoriasis (PsO) undergoing rheumatological assessment, single centre
Participants
1,023 patients
Exposure
PsO patients treated at least once with biologics vs never treated with biologics
Outcome
PsA development (prevalence)
Methodological detailsmonocentric cohort, multivariate logistic regression adjusted for main psoriatic arthritis (PsA) risk factors
  • Monocentric cohort
  • Multivariate logistic regression adjusted for main PsA risk factors

Main finding

PsA prevalence

Adjusted odds ratio

0.228

P < 0.01

By group

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeaORP value
PsA development, subgroup with PsO onset after 20050.264P < 0.01
PsA development, subgroup with PsO onset after 20140.179P < 0.01
PsA development by biologic classTNFi vs Never biologics0.206P < 0.01
PsA development by biologic classIL-17i vs Never biologics0.051P < 0.01
PsA development by biologic classIL-23 or 12/23 inhibitors vs Never biologics0.167P < 0.01
Prevalence by PsA patternBiologics vs Never biologics · pure peripheral PsA0.182P < 0.04
Prevalence by PsA patternBiologics vs Never biologics · peripheral PsA with axial involvement0.115P < 0.04

Original publication

Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development. Rheumatology (Oxford). Published 23 May 2024. doi:10.1093/rheumatology/keae257

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.